Skip to content
Disclosery

ALLIANCEBERNSTEIN L.P.: QFIN position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ALLIANCEBERNSTEIN L.P. on QFIN, newest first. How the timeline and the estimate are built.

ALLIANCEBERNSTEIN L.P. held 0 QFIN shares at 2025-12-31 per its 13F-HR filed 2026-02-17.

the latest 13F is the newest step

  1. period ended2025-12-31
    13F 0 shares
    Change vs previous 13F -89,941 shares

    13F-HR 0001109448-26-000021 filed by ALLIANCEBERNSTEIN L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-09-30
    13F 89,941 shares
    Change vs previous 13F -3,367,883 shares

    <0.01% of the 13F portfolio, value $2,588,502.

    13F-HR 0001109448-25-000079 filed by ALLIANCEBERNSTEIN L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-06-30
    13F 3,457,824 shares
    Change vs previous 13F +556,258 shares

    0.05% of the 13F portfolio, value $149,931,249.

    13F-HR 0001532155-25-000161 filed by ALLIANCEBERNSTEIN L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-03-31
    13F 2,901,566 shares
    Change vs previous 13F +500,573 shares

    0.05% of the 13F portfolio, value $130,309,329.

    13F-HR 0001532155-25-000116 filed by ALLIANCEBERNSTEIN L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-12-31
    13F 2,400,993 shares
    Change vs previous 13F not available

    0.03% of the 13F portfolio, value $92,150,111.

    13F-HR 0001532155-25-000050 filed by ALLIANCEBERNSTEIN L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).